Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Sleep Apnea01:21

Sleep Apnea

449
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
449
Management of Insomnia01:19

Management of Insomnia

499
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
499
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

477
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
477
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

1.3K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.3K
Inhaled Medications01:23

Inhaled Medications

687
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
687
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.1K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Prediction of 90-day mortality after acute ischemic stroke using the National Institutes of Health Stroke Scale alone.

Clinical neurology and neurosurgery·2026
Same author

GLP-1 RAs in Substance Use Disorders: Emerging Evidence and Future Directions.

Cardiology in review·2026
Same author

Congenital Atrioventricular Block: Comprehensive Review of Pathophysiology, Management, and Future Therapeutic Directions.

Cardiology in review·2025
Same author

Flavoprotein fluorescence elevation is a marker of mitochondrial oxidative stress in patients with retinal disease.

Frontiers in ophthalmology·2024
Same author

Lipoprotein(a): A Review of Risk Factors, Measurements, and Novel Treatment Modalities.

Cardiology in review·2024
Same author

A New Era in Stroke Care.

Cardiology in review·2024

相关实验视频

Updated: Jan 8, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.4K

对阻塞性睡眠呼吸暂停的药物

Jason Macanian1, Noah Schechter1, William H Frishman1,2

  • 1From the Department of Medicine, Westchester Medical Center, New York Medical College, Valhalla, NY.

Cardiology in review
|December 17, 2025
PubMed
概括

新的口服药物,包括GLP-1受体激动剂,通过促进体重减轻,为阻塞性睡眠呼吸暂停 (OSA) 提供有效的治疗方法. 其他新型药物可以提供快速缓解独立于体重,改善患者的坚持和结果.

关键词:
AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109 AD109作为GLP-1受体的激动剂.阻塞性睡眠呼吸暂停症是什么这就是Tirzepatide.减肥 减肥 减肥 减肥 减肥 减肥

更多相关视频

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.3K
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

3.3K

相关实验视频

Last Updated: Jan 8, 2026

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

20.4K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

1.3K
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

3.3K

科学领域:

  • 睡眠医学 睡眠医学
  • 药理学 药理学是指药理学的学科.
  • 肥胖医学 肥胖医学

背景情况:

  • 阻塞性睡眠呼吸暂停 (OSA) 是一种普遍的疾病,其特点是气道缩和睡眠障碍.
  • 持续正气道压力 (CPAP) 是标准的治疗方法,但面临着坚持挑战.
  • 减肥是OSA肥胖患者的一个关键干预措施,减少呼吸道脂肪和呼吸暂停的严重程度.

研究的目的:

  • 审查新兴的OSA口服药物治疗方法.
  • 评估GLP-1受体激动剂和其他新型药物的疗效.
  • 讨论OSA管理和患者结果的潜在改进.

主要方法:

  • 对GLP-1受体激活剂的临床试验 (例如,SURMOUNT-OSA,SCALE睡眠呼吸暂停) 的审查.
  • 对其他口服治疗方法 (如阿托莫克西丁和阿洛西布丁) 的研究分析 (AD109).
  • 评估作用机制,包括减肥和抗炎作用.

主要成果:

  • GLP-1受体激动剂显著降低OSA肥胖患者的呼吸暂停-呼吸暂停指数,主要是通过减肥.
  • 新兴的口服药物,如阿托莫克西丁和阿洛西布丁,有望迅速缓解症状,无论体重如何.
  • 与CPAP相比,这些新疗法可能会改善坚持和减少心脏代谢并发症.

结论:

  • 新型口服药物代表了OSA治疗的重大进步.
  • 由GLP-1受体激动剂诱导的减肥是疗效的主要驱动因素.
  • 未来的研究应该专注于长期结果,患者选择和组合疗法.